• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚(DL-丙交酯-共-乙交酯)纳米粒的制备及特性研究及其在 siRNA 递送中的应用。

Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.

机构信息

Department of Pharmaceutics and Analytical Chemistry, The Faculty of Pharmaceutical Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

出版信息

Int J Pharm. 2010 May 5;390(1):70-5. doi: 10.1016/j.ijpharm.2009.10.023. Epub 2009 Oct 15.

DOI:10.1016/j.ijpharm.2009.10.023
PMID:19836438
Abstract

Synthetic short interfering RNA (siRNA) is promising for specific and efficient knockdown of disease-related genes. However, in vivo application of siRNA requires an effective delivery system. Commonly used siRNA carriers are based on polycations, which form electrostatic complexes with siRNA. Such poly- or lipoplexes are of limited use in vivo due to severe problems associated with toxicity, serum instability and non-specific immune-responses. The aim of the present study was to prepare uniformly sized nanoparticles (NPs) with a high load of siRNA by use of the safe and biodegradable poly-(DL-lactide-co-glycolide) (PLGA) polymer without including polycations. The siRNA was encapsulated in the core of NPs by the double emulsion solvent evaporation method. To optimize the NP formulation, the effects of important formulation and processing parameters were investigated systematically. Generally, spherical siRNA-loaded NPs (<300 nm, PDI<0.2, zeta potential -40 mV) were obtained. An encapsulation efficiency of up to 57% was achieved by adjusting the inner water phase volume, the PLGA concentration, the first emulsification sonication time, and stabilization of the water-oil interface with serum albumin. The integrity of siRNA was preserved during the preparation. Preparation of core-loaded siRNA-NPs based on PLGA and no cationic excipient seems possible and promising for delivery of siRNA.

摘要

合成短干扰 RNA(siRNA)是一种很有前途的方法,可以特异性和有效地敲低与疾病相关的基因。然而,siRNA 的体内应用需要有效的递送系统。常用的 siRNA 载体基于聚阳离子,它与 siRNA 形成静电复合物。由于毒性、血清不稳定性和非特异性免疫反应等严重问题,这种聚阳离子或脂质体在体内的应用受到限制。本研究旨在使用安全且可生物降解的聚(DL-丙交酯-共-乙交酯)(PLGA)聚合物,而不包含聚阳离子,制备具有高负载量 siRNA 的均匀大小的纳米颗粒(NPs)。通过双乳液溶剂蒸发法将 siRNA 包封在 NPs 的核心中。为了优化 NP 配方,系统研究了重要的配方和处理参数的影响。通常,可获得负载 siRNA 的 NPs(<300nm,PDI<0.2,zeta 电位-40mV)。通过调整内水相体积、PLGA 浓度、第一次乳化超声时间以及用血清白蛋白稳定油水界面,可以实现高达 57%的包封效率。在制备过程中保持了 siRNA 的完整性。基于 PLGA 且不含阳离子赋形剂的载有 siRNA 的核芯 NPs 的制备似乎是可行且有前途的,可用于 siRNA 的递药。

相似文献

1
Preparation and characterization of poly(DL-lactide-co-glycolide) nanoparticles for siRNA delivery.聚(DL-丙交酯-共-乙交酯)纳米粒的制备及特性研究及其在 siRNA 递送中的应用。
Int J Pharm. 2010 May 5;390(1):70-5. doi: 10.1016/j.ijpharm.2009.10.023. Epub 2009 Oct 15.
2
High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: quality by design optimization and characterization.载药量高且能持续释放 siRNA 的 PLGA 纳米粒:基于质量源于设计的优化和表征。
Eur J Pharm Biopharm. 2011 Jan;77(1):26-35. doi: 10.1016/j.ejpb.2010.11.008. Epub 2010 Nov 18.
3
Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.制备变量对通过乳化扩散法制备的负载小干扰RNA的聚(D,L-丙交酯-共-乙交酯)-壳聚糖亚微米颗粒的影响。
J Microencapsul. 2008 Dec;25(8):541-8. doi: 10.1080/02652040802075567.
4
Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.改良的纳米沉淀法制备载 DNA 的 PLGA 纳米粒。
Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.
5
Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing.壳聚糖修饰的聚(D,L-乳酸-共-乙醇酸)纳米球用于质粒 DNA 递送和 HBV 基因沉默。
Int J Pharm. 2011 Aug 30;415(1-2):259-66. doi: 10.1016/j.ijpharm.2011.05.053. Epub 2011 May 27.
6
Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.通过自发乳液扩散法制备用于小干扰RNA递送的聚乙二胺掺入的聚(D,L-丙交酯-共-乙交酯)纳米颗粒。
Int J Pharm. 2009 Mar 18;369(1-2):144-54. doi: 10.1016/j.ijpharm.2008.10.012. Epub 2008 Nov 1.
7
In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.负载紫杉醇的甲氧基聚乙二醇-聚乳酸-羟基乙酸共聚物纳米粒对喉癌细胞的体外评价
Anticancer Drugs. 2009 Oct;20(9):807-14. doi: 10.1097/CAD.0b013e328330c811.
8
Preparation and antibacterial activity evaluation of rifampicin-loaded poly lactide-co-glycolide nanoparticles.载利福平聚乳酸-羟基乙酸共聚物纳米粒的制备及抗菌活性评价
Nanomedicine. 2007 Jun;3(2):161-7. doi: 10.1016/j.nano.2007.03.003. Epub 2007 Apr 30.
9
Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.聚乳酸-羟基乙酸共聚物(PLGA)作为聚合物乳化剂对载亲水性蛋白质固体脂质纳米粒制备的影响。
Colloids Surf B Biointerfaces. 2008 Dec 1;67(2):199-204. doi: 10.1016/j.colsurfb.2008.08.018. Epub 2008 Aug 27.
10
Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content.载氟哌啶醇的聚乳酸-羟基乙酸共聚物纳米粒:粒径与药物含量的系统研究
Int J Pharm. 2007 May 24;336(2):367-75. doi: 10.1016/j.ijpharm.2006.11.061. Epub 2006 Dec 5.

引用本文的文献

1
Investigation of the protein corona and biodistribution profile of polymeric nanoparticles for intra-amniotic delivery.用于羊膜腔内给药的聚合物纳米颗粒的蛋白质冠层和生物分布概况研究。
Biomaterials. 2025 Sep;320:123238. doi: 10.1016/j.biomaterials.2025.123238. Epub 2025 Mar 6.
2
Poly(lactic-co-glycolic acid) nanoparticle fabrication, functionalization, and biological considerations for drug delivery.聚(乳酸-乙醇酸)纳米颗粒的制备、功能化及药物递送的生物学考量
Biomicrofluidics. 2024 Sep 17;18(5):051503. doi: 10.1063/5.0201465. eCollection 2024 Sep.
3
Determining Ultrasound Parameters for Bursting Polymer Microbubbles for Future Use in Spinal Cord Injury.
确定用于未来脊髓损伤的爆裂聚合物微泡的超声参数。
Ultrasound Med Biol. 2024 Jun;50(6):888-897. doi: 10.1016/j.ultrasmedbio.2024.02.014. Epub 2024 Mar 22.
4
TPGS-modified Chitosan Nanoparticles of EGFR Inhibitor: Physicochemical and Evaluation against HepG2 Cell Lines.表皮生长因子受体抑制剂的TPGS修饰壳聚糖纳米颗粒:理化性质及对肝癌细胞系HepG2的评价
Curr Drug Deliv. 2025;22(4):465-478. doi: 10.2174/0115672018268315231206045504.
5
The landscape of nanoparticle-based siRNA delivery and therapeutic development.基于纳米颗粒的小干扰RNA递送与治疗发展概况。
Mol Ther. 2024 Feb 7;32(2):284-312. doi: 10.1016/j.ymthe.2024.01.005. Epub 2024 Jan 10.
6
Molecular Characterization of U6 Promoters from Orange-Spotted Grouper (Epinephelus coioides) and Its Application in DNA Vector-Based RNAi Technology.橙点石斑鱼(Epinephelus coioides)U6 启动子的分子特征及其在基于 DNA 载体的 RNAi 技术中的应用。
Mar Biotechnol (NY). 2023 Jun;25(3):388-402. doi: 10.1007/s10126-023-10212-9. Epub 2023 May 8.
7
Single pot organic solvent-free thermocycling technology for siRNA-ionizable LNPs: a proof-of-concept approach for alternative to microfluidics.单釜无溶剂热循环技术用于 siRNA-可离子化 LNPs:替代微流控的概念验证方法。
Drug Deliv. 2022 Dec;29(1):2644-2657. doi: 10.1080/10717544.2022.2108523.
8
MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization.负载微小RNA-539-5p且接枝整合素靶向肽(iRGD)的聚乳酸-羟基乙酸共聚物纳米粒用于脉络膜新生血管的靶向治疗
Pharmaceutics. 2022 Jan 20;14(2):243. doi: 10.3390/pharmaceutics14020243.
9
Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization, and Evaluation.使用聚乳酸-羟基乙酸共聚物纳米颗粒提高盐酸莫西沙星的眼部生物利用度:制备、表征及评价
Iran J Pharm Res. 2021 Summer;20(3):592-608. doi: 10.22037/ijpr.2021.114478.15054.
10
Poly(l-Lactic Acid)-co-poly(Butylene Adipate) New Block Copolymers for the Preparation of Drug-Loaded Long Acting Injectable Microparticles.用于制备载药长效注射用微粒的聚(L-乳酸)-共-聚(己二酸丁二醇酯)新型嵌段共聚物
Pharmaceutics. 2021 Jun 23;13(7):930. doi: 10.3390/pharmaceutics13070930.